IP Library Granted Patent US 8,235,990
Granted Patent B2
US 8,235,990 · App. 11/737,523 · Granted Aug 7, 2012

Vacuum coagulation probes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,235,990
App. No.
11/737,523
Granted
Aug 7, 2012
Kind
B2
Abstract

Methods for using a surgical device integrating a suction mechanism with a coagulation mechanism for improving lesion creation capabilities. The device comprises an elongate member having an insulative covering attached about means for coagulating soft tissue. Openings through the covering expose regions of the coagulation-causing elements and are coupled to lumens in the elongate member which are routed to a vacuum source and a fluid source to passively transport fluid along the contacted soft tissue surface in order to push the maximum temperature deeper into tissue.

Claims (47)

1. A method of creating a lesion on an irregular surface of soft tissue, the method comprising:

advancing a treatment device to the irregular surface, where the treatment device comprises an opening exposing an electrode, the treatment device also comprising a vacuum lumen in fluid communication with a vacuum source and a fluid perfusion lumen in fluid communication with a fluid source, where both the vacuum lumen and fluid perfusion lumen are fluidly coupled to the opening;

drawing a vacuum in the vacuum source to cause a drop in pressure in both the vacuum lumen and the opening, whereupon placing the opening against the soft tissue creates a seal against the soft tissue to cause the fluid perfusion lumen to drop in pressure resulting in fluid flow from the fluid source through the fluid perfusion lumen across the opening and through the vacuum lumen, where when uncovered the opening prevents the perfusion lumen from reducing in pressure preventing fluid flow; and

energizing the electrode during the fluid flow to create the lesion in the irregular surface of soft tissue.

2. The method of claim 1 , where energizing the electrode during the fluid flow to create the lesion in the irregular surface of soft tissue comprises applying RF energy to the electrode to create a contiguous transmural lesion in atrial tissue.

3. The method of claim 2 , where creating the contiguous transmural lesion comprises creating a series of contiguous transmural lesions.

4. The method of claim 2 , where advancing the treatment device to the irregular surface of soft tissue comprises advancing the treatment device to a plurality of regions to create a pattern of lesions in atrial tissue.

5. The method of claim 2 , where the RF energy comprises a unipolar mode, and further comprising placing a reference element in electrical contact with tissue.

6. The method of claim 2 , where the RF energy comprises a bipolar mode.

7. The method of claim 1 , where advancing the treatment device to the irregular surface the soft tissue comprises advancing the treatment device to a liver, prostate, colon, esophagus, gastrointestinal region, and gynecological region.

8. The method of claim 1 , where advancing the treatment device to the irregular surface of the soft tissue comprises advancing the treatment device during a procedure selected from the group consisting of an arthroscopic, laparoscopic, and other minimally invasive procedure.

9. The method of claim 1 , where energizing the electrode during the fluid flow to create the lesion in the irregular surface of soft tissue comprises applying vibrational energy to the electrode to create a contiguous transmural lesion in atrial tissue.

10. The method of claim 1 , where the electrode has a length and conforms to the irregular surface of soft tissue to create a curvilinear lesion.

11. The method of claim 1 , where a portion of the treatment device housing the electrode is pre-shapeable to assume a shape and where the lesion forms the shape.

12. The method of claim 1 , further comprising advancing a track adjacent to the irregular surface and where advancing the treatment device to the irregular surface comprises advancing the treatment device over the track.

13. The method of claim 12 , where the track comprises a device selected from the group consisting of a wire, a steerable catheter, a steerable guide-wire, a shaped tube, and a shaped mandrel.

14. A method of creating a curvilinear lesion along an irregular tissue surface, the method comprising:

advancing a treatment device to the irregular surface, where the treatment device comprises an opening exposing an electrode having a length, the treatment device also comprising a vacuum lumen coupled to a vacuum source and a fluid perfusion lumen coupled to a fluid source, where both the vacuum lumen and fluid perfusion lumen are fluidly coupled to the opening;

drawing a vacuum in the vacuum source to drop pressure in both the vacuum lumen and the opening, such that when the opening is placed against the irregular tissue surface, the tissue surface forms a seal against the opening, where formation of the seal drops pressure in the fluid perfusion lumen causing fluid flow from the fluid source through the fluid perfusion lumen across the opening and through the vacuum lumen; and

energizing the electrode during the fluid flow to create the linear lesion along the length of the electrode in the irregular tissue surface.

15. The method of claim 14 , where energizing the electrode during the fluid flow to create the lesion in the irregular surface of soft tissue comprises applying RF energy to the electrode to create a contiguous transmural lesion in atrial tissue.

16. The method of claim 15 , where creating the contiguous transmural lesion comprises creating a series of contiguous transmural lesions.

17. The method of claim 15 , where advancing the treatment device to the irregular surface of soft tissue comprises advancing the treatment device to a plurality of regions to create a pattern of lesions in atrial tissue.

18. The method of claim 15 , where the RF energy comprises a unipolar mode, and further comprising placing a reference element in electrical contact with tissue.

19. The method of claim 15 , where the RF energy comprises a bipolar mode.

20. The method of claim 1 , where advancing the treatment device to the irregular surface the soft tissue comprises advancing the treatment device to a liver, prostate, colon, esophagus, gastrointestinal region, and gynecological region.

21. The method of claim 14 , where advancing the treatment device to the irregular surface of the soft tissue comprises advancing the treatment device during a procedure selected from the group consisting of an arthroscopic, laparoscopic, and other minimally invasive procedure.

22. The method of claim 14 , where energizing the electrode during the fluid flow to create the lesion in the irregular surface of soft tissue comprises applying vibrational energy to the electrode to create a contiguous transmural lesion in atrial tissue.

23. The method of claim 14 , where a portion of the treatment device housing the electrode is pre-shapeable to assume a shape and where the lesion forms the shape.

24. The method of claim 14 , further comprising advancing a track adjacent to the irregular surface and where advancing the treatment device to the irregular surface comprises advancing the treatment device over the track.

25. The method of claim 24 , where the track comprises a device selected from the group consisting of a wire, a steerable catheter, a steerable guide-wire, a shaped tube, and a shaped mandrel.

26. A method of treating soft tissue, with a treatment device having a fluid circuit comprising a vacuum lumen fluidly coupled to a vacuum source, a perfusion lumen fluidly coupled to a fluid source, and an opening in the device fluidly coupled to both the perfusion lumen and the vacuum lumen, where the opening also contains an electrode, the method comprising:

applying vacuum to the vacuum lumen, where the opening causes the fluid circuit to be an open fluid circuit through which no fluid flow can occur;

closing the fluid circuit by placing the opening against soft tissue to form a seal against the soft tissue, where closing the fluid circuit causes fluid from the fluid source to flow in the fluid circuit; and

energizing the electrode to treat the soft tissue during fluid flow by confirming engagement of the electrode against tissue in the opening using the fluid flow.

27. The method of claim 26 , where applying vacuum occurs after closing the fluid circuit.

28. The method of claim 26 , where energizing the electrode during the fluid flow to treat the soft tissue comprises applying RF energy to the electrode to create a contiguous transmural lesion in atrial tissue.

29. The method of claim 28 , where creating the contiguous transmural lesion comprises creating a series of contiguous transmural lesions.

30. The method of claim 28 , where the RF energy comprises a unipolar mode, and further comprising placing a reference element in electrical contact with tissue.

31. The method of claim 28 , where the RF energy comprises a bipolar mode.

32. The method of claim 26 , where advancing the treatment device to the irregular surface the soft tissue comprises advancing the treatment device to a liver, prostate, colon, esophagus, gastrointestinal region, and gynecological region.

33. The method of claim 26 , where advancing the treatment device to the irregular surface of the soft tissue comprises advancing the treatment device during a procedure selected from the group consisting of an arthroscopic, laparoscopic, and other minimally invasive procedure.

34. The method of claim 26 , where energizing the electrode during the fluid flow to create the lesion in the irregular surface of soft tissue comprises applying vibrational energy to the electrode to create a contiguous transmural lesion in atrial tissue.

35. The method of claim 26 , where the electrode has a length and conforms to the irregular surface of soft tissue to create a curvilinear lesion.

36. The method of claim 26 , where a portion of the treatment device housing the electrode is pre-shapeable to assume a shape and where the lesion forms the shape.

37. The method of claim 26 , further comprising advancing a track adjacent to the irregular surface and where advancing the treatment device to the irregular surface comprises advancing the treatment device over the track.

38. The method of claim 37 , where the track comprises a device selected from the group consisting of a wire, a steerable catheter, a steerable guide-wire, a shaped tube, and a shaped mandrel.

Assignments (13)
MERGER AND CHANGE OF NAME Recorded Jan 28, 2026
From: NCONTACT SURGICAL, INC.; SECOND PORTAL MERGER SUB, LLC
To: NCONTACT SURGICAL, LLC
Reel/Frame 073617/0340 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2016
From: NCONTACT SURGICAL, LLC
To: ATRICURE, INC.
Reel/Frame 038062/0392 →
RELEASE OF SECURITY INTEREST Recorded Feb 22, 2011
From: INTERSOUTH PARTNERS VI, L.P.; HARBERT VENTURE PARTNERS II, L.P.; HARBERT VENTURE PARTNERS (ANNEX FUND), LLC; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; HIPPO VENTURES, L.L.C.; FINISTERE-CHICAGO PARTNERS FUND I, L.P.; FINISTERE-OCEANIA PARTNERS FUND I, L.P.
To: NCONTACT SURGICAL, INC.
Reel/Frame 025841/0380 →
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2011
From: INTERSOUTH PARTNERS VI, L.P.; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; HIPPO VENTURES, L.L.C.; FINISTERE-CHICAGO PARTNERS FUND I, L.P.; FINISTERE-OCEANIA PARTNERS FUND I, L.P.; HARBERT VENTURE PARTNERS II, L.P.
To: NCONTACT SURGICAL, INC.
Reel/Frame 025837/0119 →
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2011
From: DAUGHERTY, DENNIS
To: NCONTACT SURGICAL, INC.
Reel/Frame 025836/0648 →
SECURITY AGREEMENT Recorded Aug 20, 2010
From: NCONTACT SURGICAL, INC.
To: INTERSOUTH PARTNERS VI, L.P.; HARBERT VENTURE PARTNERS II, L.P.; HARBERT VENTURE PARTNERS (ANNEX FUND), LLC; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; FINISTERE-CHICAGO PARTNERS FUND I L.P.; FINISTERE-OCEANIA PARTNERS FUND I L.P.; HIPPO VENTURES, L.L.C.
Reel/Frame 024864/0206 →
SECURITY AGREEMENT Recorded Jun 4, 2010
From: NCONTACT SURGICAL, INC.
To: INTERSOUTH PARTNERS VI, L.P.; HARBERT VENTURE PARTNERS II, L.P.; MASSEY BURCH VENTURE FUND II, L.P.; TALL OAKS ABLATRICS PARTNERS, LP; FINISTERE-CHICAGO PARTNERS FUND I L.P.; FINISTERE-OCEANIA PARTNERS FUND I L.P.; HIPPO VENTURES, L.L.C.
Reel/Frame 024483/0767 →
SECURITY AGREEMENT Recorded Feb 12, 2010
From: NCONTACT SURGICAL, INC.
To: DAUGHERTY, DENNIS
Reel/Frame 023928/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2007
From: WHAYNE, JAMES G.; FLEISCHMAN, SIDNEY D.; ROGERS, EARL WAYNE
To: NCONTACT SURGICAL, INC.
Reel/Frame 019533/0350 →